Ingela Franck Lissbrant

13PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applications in healthPredictive and prognostic markersData mining and knowledge discoveryMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 13, 2025
Radium-223 use and survival by line of treatment in metastatic castration-resistant prostate cancer: a nationwide population-based register study.

Charlotte Alverbratt, Fredrik Sandin, Viktor Kolmbäck

|Feb 02, 2022
Time difference in retrieving clinical information in Patient-overview Prostate Cancer compared to electronic health records.

Charlotte Alverbratt, Hanna Vikman, Marie Hjälm Eriksson

|Jan 04, 2022
Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study.

Rolf Gedeborg, Hans Garmo, Camilla Thellenberg-Karlsson

|Sep 17, 2021
Time on treatment with abiraterone and enzalutamide in the Patient-overview Prostate Cancer in The National Prostate Cancer Register of Sweden.

Giuseppe Fallara, Charlotte Alverbratt, Hans Garmo

|Apr 29, 2021
Prostate cancer diagnosis, staging, and treatment in Sweden during the first phase of the COVID-19 pandemic.

Giuseppe Fallara, Fredrik Sandin, Johan Styrke

|Mar 06, 2021
The Value of Real-World Data in Understanding Prostate Cancer Risk and Improving Clinical Care: Examples from Swedish Registries.

Kerri Beckmann, Hans Garmo, Ingela Franck Lissbrant

Pageof 3

Frequent Collaborators

5 joint publications

Hans Garmo

4 joint publications

Giuseppe Fallara

3 joint publications

Pär Stattin

1 joint publications

Yasin Folkvaljon